PURE Bioscience Announces Fiscal Year 2024 Financial Results
PURE Bioscience, Inc. (OTCQB: PURE), renowned for its innovative, non-toxic silver dihydrogen citrate (SDC) antimicrobial technology, has reported its financial performance for the recently concluded fiscal year.
Results Summary for Year-End Operations
In terms of net product sales, the company recorded impressive numbers. For the fiscal year concluded July 31, 2024, net product sales amounted to $1,955,000, up from $1,871,000 the previous year. This increase of $84,000 indicates a positive trend in sales across its distribution channels.
Loss Evaluation
The net loss for the fiscal year 2024 was reported at $3.4 million, an improvement compared to the net loss of $3.9 million in the prior year. When excluding share-based compensation, the adjusted net loss for the year was $3.1 million, compared to $3.6 million for 2023. The net loss per share for 2024 stood at ($0.03) compared to ($0.04) for 2023.
Cash Utilization
Another critical financial metric is cash flow, where the net cash used in operations for 2024 was $2.5 million, significantly lower than the $3.3 million from the previous year. These figures indicate a positive stride towards improving cash management.
Strategic Business Developments
During the second quarter of the fiscal year, PURE refined its business strategy, pivoting from a customer-focused approach to a more robust distribution model. The company has successfully partnered with several distributors, allowing for a more extensive reach across multiple geographic locations within the United States.
Future Perspectives
As part of its forward-looking initiatives, PURE is focused on continuing to establish additional distributor partnerships. The company is also dedicated to expanding product offerings and application methods, particularly within the food and beverage sector, which underscores its commitment to innovation.
Research and Development Insights
Current research and development initiatives are being undertaken in collaboration with academic leaders and scientists within its distribution network. These efforts are geared towards creating validated “Clean-in-Place” protocols, facilitating the cleaning and sanitization of food processing equipment without disassembly. By validating these methods, PURE aims to bolster food safety and efficiency, ultimately benefiting both food producers and consumers.
CEO Commentary
Robert Bartlett, Chief Executive Officer, shared insights on the year’s journey, stating, "We have expanded our business strategy to emphasize a distribution business model, thereby enhancing our service offerings across the United States. Partnering with distributors empowers our technical teams to address unmet needs in their respective industries and resolves pertinent food safety challenges. We are excited about the progress and look forward to sharing these developments with our shareholders as we continue to learn and adapt.”
About PURE Bioscience, Inc.
PURE is steadfast in its mission to redefine chemical safety through advanced technology solutions. With a strong focus on creating effective antimicrobial products, primarily targeting the food and beverage industry, PURE addresses health-related environmental challenges posed by pathogens and sanitation practices. The technology is based on patented stabilized ionic silver, prominently using silver dihydrogen citrate (SDC). This compound is recognized for its broad-spectrum efficacy, low toxicity, and ability to help mitigate bacterial resistance, making it an ideal choice in today's market.
Frequently Asked Questions
What are the key financial highlights of PURE for 2024?
Key highlights include a net product sales increase to $1,955,000, reduced net loss to $3.4 million, and improved cash flow management.
How has PURE Bioscience adjusted its business strategy?
PURE has moved from a direct customer strategy to developing a distribution model in response to market demands and growth opportunities.
What innovations is PURE pursuing in the food industry?
PURE is focusing on new application methods and cleaning solutions to enhance safety and efficiency within the food and beverage sectors.
What did the CEO say about the company's future plans?
The CEO emphasized the importance of distributor partnerships in expanding service offerings and addressing food safety issues.
Where can additional information about PURE be found?
Additional information about PURE Bioscience can be accessed through its official website.
